Dermatology clinical trials recruiting in California

75 recruiting dermatology trials match in California. Showing 20.

• A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of LutikizumabRecruiting

  Phase 2 · AbbVie · Sacramento, California

• Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic ArthritisRecruiting

  Phase 2 · AbbVie · Huntington Beach, California

• A Study Evaluating BFB759 in Moderate to Severe Hidradenitis SuppurativaRecruiting

  Phase 2 / Phase 3 · Bluefin Biomedicine, Inc. · Encino, California

• Molecular Signatures of Cutaneous Dupilumab ResponseRecruiting

  Phase 4 · University of California, San Francisco · San Francisco, California

• Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque PsoriasisRecruiting

  Phase 2 · Oruka Therapeutics, Inc. · Fountain Valley, California

• Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced DietRecruiting

  N/A · University of California, Davis · Sacramento, California

• Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)Recruiting

  Phase 2 · Merck Sharp & Dohme LLC · Riverside, California

• Lebrikizumab in Moderate-to-severe Atopic DermatitisRecruiting

  Phase 4 · Johann E Gudjonsson MD PhD · Folsom, California

• Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild AcneRecruiting

  Phase 1 / Phase 2 · Sanofi Pasteur, a Sanofi Company · Encino, California

• A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic DermatitisRecruiting

  Phase 2 · Janssen Research & Development, LLC · São Paulo

• A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne ScarsRecruiting

  Phase 3 · AbbVie · Redondo Beach, California

• A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsRecruiting

  Phase 1 · UCB Biopharma SRL · Apple Valley, California

• A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque PsoriasisRecruiting

  Phase 4 · Bausch Health Americas, Inc. · Thousand Oaks, California

• A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)Recruiting

  Phase 4 · Eli Lilly and Company · Apple Valley, California

• A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)Recruiting

  Phase 1 · Bambusa Therapeutics · New York, New York

• A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic DermatitisRecruiting

  Phase 3 · AbbVie · Palo Alto, California

• A Study of Zasocitinib in Adults With Nonsegmental VitiligoRecruiting

  Phase 2 · Takeda · Fountain Valley, California

• A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic DermatitisRecruiting

  Phase 2 · UCB Biopharma SRL · Oceanside, California

• A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque PsoriasisRecruiting

  Phase 2 · InventisBio Co., Ltd · Chula Vista, California

• Correction of Psoriatic T Cell Signatures by DeucravacitinibRecruiting

  Phase 4 · University of California, San Francisco · San Francisco, California

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.